FSAGX | OCMAX | FSAGX / OCMAX | |
Total Expense Ratio | 0.70 | 1.94 | 36% |
Annual Report Gross Expense Ratio | 0.70 | 1.94 | 36% |
Fund Existence | 39 years | 15 years | - |
Gain YTD | 22.905 | 25.953 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.93B | 82.7M | 2,337% |
Annual Yield % from dividends | 2.71 | 1.72 | 157% |
Returns for 1 year | 29.50 | 37.00 | 80% |
Returns for 3 years | 3.01 | 16.15 | 19% |
Returns for 5 years | 40.40 | 86.95 | 46% |
Returns for 10 years | 97.77 | 77.42 | 126% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDWM | 20.80 | 1.77 | +9.28% |
Fidelity Women's Leadership ETF | |||
AVSD | 57.87 | 4.03 | +7.48% |
Avantis Responsible International Eq ETF | |||
FMED | 22.85 | 1.42 | +6.63% |
Fidelity Disruptive Medicine ETF | |||
ACIO | 37.97 | 1.61 | +4.44% |
Aptus Collared Investment Opp ETF | |||
TBUX | 49.58 | -0.01 | -0.02% |
T. Rowe Price Ultra Short-Term Bond ETF |